BioCatalyst

SAR445877, Cetuximab, ADG126, Bevacizumab — catalyst calendar

1 verified catalyst event(s) referencing SAR445877, Cetuximab, ADG126, Bevacizumab, each linked to its official source. Verified as of 2026-10-01.

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-01-19
in 4mo
ESTIMATED
 READOUT
A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult
Phase 1/2 · Solid Tumor
 SNY Sanofi SAR445877, Cetuximab, ADG126, Bevacizuma ClinicalTrials.gov ↗
✓ Source-checked 2026-10-01
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.